
|Articles|September 1, 2007
- Psychiatric Times Vol 24 No 10
- Volume 24
- Issue 10
New Patient
Author(s)Richard M. Berlin, MD
Poetry of the Times
Advertisement
If you have read my poems you know
I am a man who rides trains facing backwards,
which is how I read books of poetry,
last poem first, the way I will read
the lesions on your arms
like lines from a tattered timetable
as we follow your tracks
back to that sunrise at the station
when your creases were sharp
and your wallet bulged with big bills,
her perfume clinging to your collar,
your dark eyes dancing down a line
toward a future you never imagined
would include this morning with me.
Articles in this issue
about 19 years ago
Clinical Depression: Complexities of Diagnosis and Managementabout 19 years ago
The Substance Abuse Handbookabout 19 years ago
Placebo Effects on Pharmacotherapy Outcomes in Major Depressionabout 19 years ago
Never-Ending Winter: Chronic Depressionabout 19 years ago
SSRIs and Pregnancy: Putting the Risks Into Perspectiveabout 19 years ago
Can We Predict Response to Antidepressants?about 19 years ago
Not Obsolete: Continuing Roles for TCAs and MAOIsAdvertisement
Related to this article

Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.

Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.

Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.

Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.

Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.

How genes and early stress interact to shape antisocial behavior, from dopamine and serotonin pathways to MAOA and oxytocin findings.

Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Clinicians Need to Know About Postpartum Psychosis
2
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
3
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
4
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
5

